The World Health Organization on Friday released a formal statement blasting a US-funded vaccine trial as “unethical,” because it would withhold an established, safe, and potentially lifesaving ...

VRC Medical Services, a women-owned specialty pharmaceutical distribution company supporting clinical research, announced the launch ...

VRC Medical Services, a women-owned specialty pharmaceutical distribution company supporting clinical research, announced the launch of a dedicated comparator support program designed to help ...

Using KRIs or SDM, sponsors can detect a variety of emerging risks, including inadequate adverse-event reporting, protocol ...

Children are being paid to take part in an NHS puberty blocker trial, The Telegraph can reveal. Some 226 children who believe they are transgender will be given puberty blockers as part of an ...

Racura Oncology scientists have developed a novel blood-based molecular test designed to assess the cardioprotective effects of its lead drug candidate RC220.

Every year, around 15 million babies worldwide are born before 37 weeks of gestation. Being born preterm can disrupt development, and earlier births increase the risk of life-changing health outcomes.

When COVID-19 initially appeared in China, clinical trial teams experienced tremendous disruption. With limited time to ...

Objectives To map the landscape of decentralised clinical trials (DCTs) by summarising characteristics, methods and reported challenges of published DCTs. Design Scoping review, reported according to ...

In the first of a two-parter, lawyers at Santarelli analyse the patentability of therapeutic inventions where publication of clinical trial protocols occurs before the application's filing date The ...

SAN FRANCISCO, Jan 26 (Reuters) - Artificial intelligence has yet to deliver on the most challenging aspect of drug development -- finding new molecules that lead to major medical advances -- but it ...

• Frequent substantial modifications for initiating new trial parts slow down development and reduce transparency. • Combining healthy volunteers and patients in a single early-phase trial raises ...